What Researchers Did
This study reviewed the current mainstays of therapy and emerging adjunctive modalities for necrotising fasciitis.
What They Found
The review found that necrotising fasciitis is a life-threatening emergency with mortality rates often exceeding 30%. Successful management relies on early and wide surgical debridement, antibiotics, and supportive care, while the effectiveness of adjunctive therapies like hyperbaric oxygen and intravenous immunoglobulin remains unproven.
What This Means for Canadian Patients
Canadian patients with suspected necrotising fasciitis require immediate clinical suspicion and aggressive treatment, including prompt surgical debridement and antibiotics, to improve outcomes. While some adjunctive therapies exist, their benefit is not yet proven, emphasizing the critical role of established standard care.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
A limitation of this review is that it reflects the state of evidence up to 2006, and it highlights the lack of definitive evidence for many adjunctive treatments.